Carpal Arch Space Augmentation (CASA) Clinical Trial

Launched by UNIVERSITY OF ARIZONA · Jan 5, 2024

Keywords

ClinConnect Summary

The Carpal Arch Space Augmentation (CASA) Clinical Trial is studying a new device designed to help people with carpal tunnel syndrome (CTS), a condition that causes pain, numbness, and weakness in the hand and wrist. This device works by gently applying a small force to the wrist while you sleep, alternating between applying and releasing pressure. The goal of the trial is to see how effective this device is compared to standard treatments for CTS, based on what patients report about their symptoms and experiences.

To participate in this trial, you must be at least 18 years old and have been diagnosed with carpal tunnel syndrome in your right hand. The study is currently looking for both men and women, but there are some important criteria to keep in mind. For instance, if you have certain chronic health conditions, a history of specific injuries, or have recently undergone other CTS treatments, you may not be eligible. If you join the study, you can expect to wear the device while you sleep and share your experiences to help researchers understand its effectiveness. This trial is an exciting opportunity to contribute to developing new ways to treat carpal tunnel syndrome.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• • 18 and older
• • Diagnosed with right-handed or bilateral CTS. Participants will be treated only in the right hand.
• • Exclusion Criteria
• • History of traumatic or chronic neuromusculoskeletal disorders involving the right upper extremity.
• • Systemic diseases (e.g. diabetes, thyroid disease, rheumatoid arthritis, gout, renal failure, hemodialysis, sarcoidosis, amyloidosis)
• • Positive diagnosis of cervical disorders such as radiculopathy, spondylosis, tumor, and multiple sclerosis
• • Degenerative joint diseases in the right hand (e.g., Osteoarthritis)
• • Osteoporosis in the right hand
• • History of carpal tunnel release in the right hand
• • History of conservative CTS treatments in the right hand within the 3 months preceding study initiation (e.g. splinting, corticosteroid injections, oral anti-inflammatory medication, physical therapy)
• • Body mass index greater than 35
• • Women who are currently pregnant
• • Patients who have carpal tunnel release surgery scheduled for the next 12 weeks.
• • Patients who have taken pain medication within 2 weeks prior to initiation of the study.
• • Will not participate in other CTS treatment or therapies during this study